Skip to main content
team

McLaughlin Centre

Advancing Genomic Medicine through Research and Education
Stephen Scherer, PhD DSc FRSC, Director, McLaughlin Centre

Message from the Director

Stephen Scherer headshot
We have hit full stride in our mission to advance genomic medicine through research and education. The Centre’s investments have been instrumental in bringing the University of Toronto to the forefront in genome sequencing and its applications in medicine. We support the world’s largest ‘open science’ genome sequencing project applied to autism. We have enabled a generous partnership between Illumina Inc. and our researchers, for the application of genome sequencing to any family in need of diagnosis.
May 13, 2026
Findings help separate the biology of core Autism Spectrum Disorder (ASD) traits from cognitive impairment and show that this non-coding gene plays a distinct role in ASD biology.
Apr 29, 2026
Dr. Venter was a visionary scientific leader whose work helped define modern genomics and launch the field of synthetic biology. He drove scientific and technological change by building interdisciplinary teams, pushing for bold ideas and faster methods, insisting that discovery should translate into real-world impact.
Jan 20, 2026
LIGAND-AI, one of the largest global open-science drug discovery efforts, to create open protein-ligand datasets for AI-driven medicine